Health Canada Clears Cepheid's MRSA Test to Combat Hospital Infections

Jan 29, 2008

NEW YORK (GenomeWeb News) – The Canadian government has licensed Cepheid’s test for methicillin-resistant Staphylococcus aureus for use in hospitals, the company said today.

The company said Health Canada’s device license for the Xpert MRSA test, which runs on the GeneXpert System and identifies MRSA in around 70 minutes, can help Canadian healthcare organizations maintain better control measures for MRSA hospital-acquired infections.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Penguins With Roving Eyes

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Funding Lost

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

This Week in Science

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

New Framework Suggested

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

Main menu